Evaluation of Pain Quality in Young Swimmers Suffering From Myofascial Pain Syndrome Using Lidocaine Phonophoresis

NCT ID: NCT06573775

Last Updated: 2024-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-05

Study Completion Date

2024-07-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate pain quality by pain quality assessment scale (PQAS) using lidocaine phonophoresis on myofascial pain syndrome (MPS) in athletic children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Forty five males athletic swimmer children (10 to 14 years old) with MPS in the upper trapezius muscle were evaluated before and after treatment. They were randomly divided into three groups, n=15 children each. A (control), B and C (study groups). The three groups received spatial designed physical therapy program. The two study groups received pulsed ultrasound and lidocaine phonophoresis repectively. The duration of treatment was 40 minutes, three times / weeks for three successive months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neck Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
sealed envelopes

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group A

the control group received the traditional physical therapy for treating myofascial trigger points in the form of a myofascial trigger point release, stretching and strengthening of the trapezius muscle

Group Type ACTIVE_COMPARATOR

myofascial release

Intervention Type OTHER

manual massage and range of motion exercises

study group B

received pulsed ultrasound in addition to traditional physical therapy for treating myofascial trigger points in the form of a myofascial trigger point release, range of motion exercises, stretching and strengthening of the trapezius muscle

Group Type EXPERIMENTAL

pulsed ultrasound

Intervention Type DEVICE

treatment of myofacial trigger points with therapeutic ultrasound

myofascial release

Intervention Type OTHER

manual massage and range of motion exercises

study group C

received lidocaine hydrochloride gel 5%phonophoresis in addition to traditional physical therapy for treating myofascial trigger points in the form of a myofascial trigger point release,range of motion exercises stretching and strengthening of the trapezius muscle

Group Type EXPERIMENTAL

myofascial release

Intervention Type OTHER

manual massage and range of motion exercises

lidocaine phonophoresis

Intervention Type DEVICE

transdermal tranmission of lidocaine molecules via ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulsed ultrasound

treatment of myofacial trigger points with therapeutic ultrasound

Intervention Type DEVICE

myofascial release

manual massage and range of motion exercises

Intervention Type OTHER

lidocaine phonophoresis

transdermal tranmission of lidocaine molecules via ultrasound

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

myofascial trigger point realease

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age range from 10 to 14 years.
* All children have regional neck pain complaint.
* Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I )
* The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005):
* Patients suffered from active MTrPs in the upper trapezius.
* Tender spots in one or more palpable taut bands.
* A typical pattern of referred pain distributed in the ipsilateral, posterolateral cervical paraspinal area, mastoid process or temporal area
* Palpable or visible local twitch response on snapping palpation at the most sensitive spot in the taut band.
* Restricted range of motion in lateral bending of the cervical spine to the opposite side.
* Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.
* Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band.
* All children allowed to practice their regular sport activities.

Exclusion Criteria

* Neurological disorders.
* Dermatological disorders.
* Acute trauma prior to the study.
* Fibromyalgia, systemic disease and drug allergy history were excluded from the study.
* Having myofascial trigger points injection.
* Chronic pain in both sides of the body.
* History of findings of cervical injury whether orthopedic or soft tissue injury
Minimum Eligible Age

10 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New Ismailia National University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Abdel Moeim Abo EL Ros

Lecturer of Physical Therapy for Pediatrics and its Surgeries

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed AM El Meligy, MD

Role: STUDY_CHAIR

Suez Canal University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

College of Medicine

Ismailia, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form: statistical plan with brief description

View Document

Document Type: Informed Consent Form: consent form with brief description

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/001708

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Magnesium Sulfate and Trigger Points
NCT06975813 NOT_YET_RECRUITING PHASE2